Neuphoria Therapeutics, Inc. (NEUP)
3.86
-0.03
(-0.77%)
USD |
NASDAQ |
Dec 19, 10:17
Neuphoria Therapeutics Total Liabilities (Quarterly): 14.83M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Adverum Biotechnologies, Inc. | 128.05M |
| Aditxt, Inc. | 20.66M |
| Recursion Pharmaceuticals, Inc. | 352.58M |
| X4 Pharmaceuticals, Inc. | 101.94M |
| Inhibrx Biosciences, Inc. | 140.64M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 27.34M |
| Shareholders Equity (Quarterly) | 12.51M |
| Debt to Equity Ratio | 0.0094 |
| Current Ratio | 2.723 |
| Net Debt Paydown Yield | -0.11% |